Treating perioral dermatitis (PD) requires a 'less is more' approach, often referred to by clinicians as 'skin fasting.' The primary step is the immediate cessation of topical corticosteroids, which are frequently the hidden culprit behind the condition's persistence and subsequent 'rebound' flares [1]. While stopping steroids may cause a temporary worsening of the rash, continuing their use leads to chronic skin atrophy and follicular inflammation. You should also eliminate potential irritants such as heavy occlusive moisturizers, fragranced products, and physical exfoliants that disrupt the compromised epidermal barrier [2].
To manage the condition without causing further irritation, transition to a minimalist routine featuring a soap-free, pH-balanced cleanser and a lightweight, non-comedogenic moisturiser. If conservative measures fail, evidence-based medical interventions include topical antibiotics like metronidazole or erythromycin, which provide anti-inflammatory benefits [3]. In more recalcitrant cases, Australian dermatologists often prescribe oral tetracyclines, such as doxycycline, to reduce the papulopustular load and stabilise the skin's microbial environment without the need for harsh topical actives [4].
Perioral dermatitis is a chronic inflammatory facial dermatosis typically characterised by erythematous papules and pustules in the perioral, perinasal, and periorbital regions. Pathophysiologically, it involves a complex interplay between a disrupted skin barrier, alterations in the follicular microflora (such as Fusobacteria), and an exaggerated immune response to external triggers [2][5]. The condition is distinct from acne or rosacea, though it shares similar inflammatory pathways involving the activation of the innate immune system.
Recent research suggests that the overuse of heavy cosmetic vehicles—such as paraffin or isopropyl myristate—can cause a 'maceration' of the stratum corneum, allowing microorganisms to proliferate within the hair follicles [1]. Furthermore, the Australian climate and lifestyle factors, including high UV exposure and the use of fluoridated toothpastes, have been implicated as potential exacerbating factors in sensitive individuals, requiring a specialised approach to photoprotection and oral hygiene during active flares [6].
For those navigating the complexities of a compromised barrier, many of our customers have found that simplifying their routine with a gentle, non-stripping cleanser like Surface Calm helps maintain skin integrity without further irritation. To support the skin’s natural recovery during this delicate time, Balance Biome Crème is formulated with Bifida Ferment Lysate and Niacinamide, providing a thoughtful way to foster microbiome resilience and calm a sensitised complexion.
FAQ
Can I use sunscreen while I have a perioral dermatitis flare?
Yes, but formulation choice is critical. Chemical filters and heavy, greasy sunscreens can exacerbate the burning sensation associated with PD. It is recommended to use a lightweight, mineral-based (zinc oxide or titanium dioxide) sunscreen designed for sensitive skin, as these are less likely to penetrate the compromised barrier and cause irritation [4][6].
Does toothpaste affect perioral dermatitis?
Some clinical observations suggest that fluoridated toothpaste or those containing sodium lauryl sulphate (SLS) can irritate the perioral area and worsen the rash in some patients [1][5]. Switching to an SLS-free, non-fluoridated toothpaste temporarily may help identify if these agents are contributing to your specific flare-up.
Is it safe to use active ingredients like Retinol or Vitamin C?
During an active perioral dermatitis flare, you should strictly avoid active ingredients including retinoids, Vitamin C (L-ascorbic acid), and hydroxy acids (AHAs/BHAs). These substances increase cellular turnover and can further weaken an already damaged skin barrier, leading to increased redness and discomfort [2][3].
References:
[1] Tempark T, et al. American Journal of Clinical Dermatology. 2014;15(1):33-46. doi:10.1007/s40257-013-0054-z.
[2] Hafeez F, et al. Journal of Clinical and Aesthetic Dermatology. 2015;8(8):34-38.
[3] Green B, et al. Australasian Journal of Dermatology. 2017;58(3):214-219. doi:10.1111/ajd.12515.
[4] Del Rosso JQ. Journal of Drugs in Dermatology. 2011;10(6):611-616.
[5] Tolaymat L, et al. StatPearls [Internet]. 2023. NBK525968.
[6] Smith K, et al. Clinical, Cosmetic and Investigational Dermatology. 2020;13:639-648. doi:10.2147/CCID.S264771.
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new skincare regimen. Content reviewed by a biomedical scientist.
